FENNEC PHARMACEUTICALS INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Fennec Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 27.4M shares, a 2.91% increase year-over-year.
  • Fennec Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 26.6M shares, a 1.14% increase from 2022.
  • Fennec Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 26.3M shares, a 1.03% increase from 2021.
  • Fennec Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 26M shares, a 9.71% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 27.4M +775K +2.91% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 27.3M +839K +3.17% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 27M +486K +1.83% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 26.6M +299K +1.14% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 26.6M +488K +1.87% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 26.5M +406K +1.56% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 26.6M +540K +2.08% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 26.3M +269K +1.03% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 26.1M +101K +0.39% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 26.1M +49K +0.19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 26M +16K +0.06% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 26M +2.3M +9.71% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 26M +409K +1.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 26M +2.61M +11.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 26M +6.11M +30.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 23.7M +3.81M +19.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 25.6M +5.7M +28.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 23.4M +3.5M +17.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 19.9M 0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 19.9M +954K +5.04% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 19.9M +928K +4.89% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 19.9M +1.31M +7.05% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 19.9M +1.47M +7.95% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 18.9M +3.93M +26.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 19M +3.23M +20.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 18.6M +4.39M +31% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 18.4M +4.79M +35.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 15M +2.25M +17.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 15.7M +2.1M +15.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 14.2M +1.38M +10.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 13.6M +2.7M +24.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 12.8M +1.94M +17.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 13.6M +2.71M +24.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 12.8M +1.98M +18.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 10.9M +337K +3.18% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 10.8M +956K +9.69% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 10.9M +1.07M +10.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 10.8M +984K +9.99% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 10.6M +836K +8.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 9.87M +152K +1.56% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 9.86M +1.48M +17.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 9.85M -15.3M -60.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 9.77M -15.4M -61.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 9.72M -15.4M -61.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 8.39M -16.8M -66.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 25.2M +25.1M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 25.2M +25.1M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 25.2M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 25.2M +7.07M +39.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 25.2K* -25.1M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 25.2K* -20.5M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q3 2011 18.1M -2.38M -11.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 25.2M -343M -93.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 20.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 20.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 368M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.